Aim: To verify if the guidelines are being followed for the treatment of patients with type 1 diabetes mellitus (T1DM) who receive insulin by lawsuits.
Methods: A descriptive study was conducted with secondary data of these patients in a Brazilian city.
Results: 53.9% acquired insulin by lawsuits without previously registered use of another insulin in the Public Health System (SUS).
Conclusion: The guidelines are not being followed for most patients analyzed, which may result in unnecessary expenses for the SUS. Therefore, this data can support the awareness of prescribers in relation to the savings generated for municipalities through the follow-up of the guidelines.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.dsx.2020.02.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.
Health Technol Assess
December 2024
Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Background: Hybrid closed-loop systems are a new class of technology to manage type 1 diabetes mellitus. The system includes a combination of real-time continuous glucose monitoring from a continuous glucose monitoring device and a control algorithm to direct insulin delivery through an insulin pump. Evidence suggests that such technologies have the potential to improve the lives of people with type 1 diabetes mellitus and their families.
View Article and Find Full Text PDFAn assessment of the factors contributing to the unavailability of drugs at outpatient pharmacy of tertiary care hospital: an observational study.
F1000Res
December 2024
Department of Hospital Administration., Datta Meghe Institute of Higher Education and research, Sawangi Meghe, Wardha., Maharashtra, 442001, India.
Introduction: Throughout history and up until the present, there has been a medicine shortage. In the early 1920s, there was a shortage of insulin, which is when drug scarcity first appeared in the records. Drug shortages are now more prevalent globally than they were back then.
View Article and Find Full Text PDFBlocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice.
Hepatol Commun
December 2024
I. Department of Medicine, University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany.
Background: An increasing number of HCC develops in the context of metabolic dysfunction-associated steatotic liver disease and its inflammatory form, metabolic dysfunction-associated steatohepatitis, even in the absence of cirrhosis. Chronic metabolic inflammation is the driving force of metabolic dysfunction-associated steatotic liver disease progression and a key factor in hepatocarcinogenesis. Given the prominent role of IL-1 signaling in inflammation and metabolic diseases, we investigated the relevance of the hepatocyte-specific IL-1 receptor type 1 knockout in metabolic dysfunction-associated steatohepatitis-related noncirrhotic HCC.
View Article and Find Full Text PDFAvailability and affordability of antidiabetic medicines in Herat of Afghanistan in 2023.
J Diabetes Metab Disord
December 2024
Medical Faculty, Ghalib University, Herat, Afghanistan.
Objectives: This study aims to investigate the availability, affordability, and accessibility of antidiabetic medications in Herat, Afghanistan, in 2023.
Methods: Adhering to WHO and HAI guidelines, a systematic survey approach was utilized to collect data on the pricing, availability, and affordability of commonly prescribed antidiabetic medications. Data collection spanned a month and involved four investigators using a standardized template.
Blood-glucose regulator design for diabetics based on LQIR-driven Sliding-Mode-Controller with self-adaptive reaching law.
PLoS One
November 2024
School of Computer Science, Faculty of Science and Engineering, University of Hull, Hull, United Kingdom.
Type I Diabetes is an endocrine disorder that prevents the pancreas from regulating the blood glucose (BG) levels in a patient's body. The ubiquitous Linear-Quadratic-Integral-Regulator (LQIR) is an optimal glycemic regulation strategy; however, it is not resilient enough to withstand measurement noise and meal disruptions. The Sliding-Mode-Controller (SMC) yields robust BG regulation effort at the expense of a discontinuous insulin infusion rate that perturbs the BG concentrations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!